Novavax

(Newser) - Update: The US is getting another COVID-19 vaccine choice. The Food and Drug Administration on Wednesday cleared Novavax shots for adults. Novavax makes a more traditional type of shot than the three other COVID-19 vaccines available for use in the US and the company hopes the protein-based vaccine will become...

(Newser) - More good news on the COVID vaccine front: A fourth company now has a strong candidate for availability in the US. Per the New York Times , the Novavax vaccine has shown an overall efficacy of 90.4% during a phase 3 trial in the US and Mexico, with 100% efficacy...

(Newser) - Novavax Inc. said Thursday that its COVID-19 vaccine appears 89% effective based on early findings from a British study and that it also seems to work—though not as well—against new mutated versions of the virus circulating in that country and South Africa. The announcement comes amid worry about...

(Newser) - Another coronavirus vaccine candidate is advancing in clinical trials, and the New York Times coverage about it carries this notable quote from a virologist: "This is the first one I’m looking at and saying, 'Yeah, I’d take that." The quote is from John Moore of...